Postes actifs de David Hyman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LOXO ONCOLOGY INC | Directeur Technique/Scientifique/R&D | 01/01/2020 | - |
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | 16/10/2023 | - |
Historique de carrière de David Hyman
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bourse
- Insiders
- David Hyman
- Expérience
